Funder
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference42 articles.
1. Abou-Alfa GK, Lau G, Kudo M et al (2022) Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma. NEJM Evid. https://doi.org/10.1056/EVIDoa2100070
2. Aly A, Ronnebaum S, Patel D et al (2020) Epidemiologic, humanistic and economic burden of hepatocellular carcinoma in the USA: a systematic literature review. Hepatic Oncology 7:27. https://doi.org/10.2217/hep-2020-0024
3. Anstee QM, Reeves HL, Kotsiliti E et al (2019) From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol 16:411–428. https://doi.org/10.1038/s41575-019-0145-7
4. Axley P, Ahmed Z, Ravi S, Singal AK (2018) Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review. J Clin Transl Hepatol 6:79–84. https://doi.org/10.14218/JCTH.2017.00067
5. Birnbaum B, Nussbaum N, Seidl-Rathkopf K et al (2020) Model-assisted cohort selection with bias analysis for generating large-scale cohorts from the EHR for oncology research
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献